<div id="readability-page-1"><p>In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Cigna, with a price target of <span id="expert-recommendation-target">$344.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>According to TipRanks, Hendrix is a 4-star analyst with an average return of <span>4.6%</span> and a 51.76% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical.</p> <p>In a report released on December 10, Bank of America Securities also reiterated a Buy rating on the stock with a $378.00 price target.</p></div>

<p>RBC Capital's Ben Hendrix maintains a Buy rating for Cigna with a $344 price target. Hendrix, a 4-star analyst, has a 4.6% average return and a 51.76% success rate. Bank of America Securities also reiterated a Buy rating with a $378 price target. Hendrix covers the Healthcare sector, including CVS Health and Select Medical.</p>

RBC Capital Sticks to Their Buy Rating for Cigna (CI)